| YEASTRACT+: a portal for cross-species comparative genomics of transcription regulation in yeasts PT Monteiro, J Oliveira, P Pais, M Antunes, M Palma, M Cavalheiro, ... Nucleic acids research 48 (D1), D642-D649, 2020 | 185 | 2020 |
| Divergent Approaches to Virulence in C. albicans and C. glabrata: Two Sides of the Same Coin M Galocha, P Pais, M Cavalheiro, D Pereira, R Viana, MC Teixeira International journal of molecular sciences 20 (9), 2345, 2019 | 83 | 2019 |
| Microevolution of the pathogenic yeasts Candida albicans and Candida glabrata during antifungal therapy and host infection P Pais, M Galocha, R Viana, M Cavalheiro, D Pereira, MC Teixeira Microbial Cell 6 (3), 142, 2019 | 55 | 2019 |
| Host-pathogen interactions mediated by MDR transporters in fungi: as pleiotropic as it gets! M Cavalheiro, P Pais, M Galocha, MC Teixeira Genes 9 (7), 332, 2018 | 33 | 2018 |
| YEASTRACT+: a portal for the exploitation of global transcription regulation and metabolic model data in yeast biotechnology and pathogenesis MC Teixeira, R Viana, M Palma, J Oliveira, M Galocha, MN Mota, ... Nucleic Acids Research 51 (D1), D785-D791, 2023 | 23 | 2023 |
| Genome-Scale Metabolic Model of the Human Pathogen Candida albicans: A Promising Platform for Drug Target Prediction R Viana, O Dias, D Lagoa, M Galocha, I Rocha, MC Teixeira Journal of Fungi 6 (3), 171, 2020 | 23 | 2020 |
| Candida glabrata transcription factor Rpn4 mediates fluconazole resistance through regulation of ergosterol biosynthesis and plasma membrane permeability P Pais, R Califórnia, M Galocha, R Viana, M Ola, M Cavalheiro, ... Antimicrobial Agents and Chemotherapy 64 (9), 10.1128/aac. 00554-20, 2020 | 22 | 2020 |
| Genome-Wide Response to Drugs and Stress in the Pathogenic Yeast Candida glabrata P Pais, M Galocha, MC Teixeira Yeasts in Biotechnology and Human Health: Physiological Genomic Approaches …, 2019 | 18 | 2019 |
| Carrier-mediated drug uptake in fungal pathogens M Galocha, IV Costa, MC Teixeira Genes 11 (11), 1324, 2020 | 10 | 2020 |
| Multiple genome analysis of Candida glabrata clinical isolates renders new insights into genetic diversity and drug resistance determinants P Pais, M Galocha, A Takahashi-Nakaguchi, H Chibana, MC Teixeira Microbial Cell 9 (11), 174, 2022 | 9 | 2022 |
| Assessing regulatory features of the current transcriptional network of Saccharomyces cerevisiae PT Monteiro, T Pedreira, M Galocha, MC Teixeira, C Chaouiya Scientific reports 10 (1), 17744, 2020 | 7 | 2020 |
| Role of CgTpo4 in Polyamine and Antimicrobial Peptide Resistance: Determining Virulence in Candida glabrata M Cavalheiro, D Romão, R Santos, D Mil-Homens, P Pais, C Costa, ... International Journal of Molecular Sciences 22 (3), 1376, 2021 | 6 | 2021 |
| Draft genome sequences of three clinical isolates of the pathogenic yeast Candida glabrata P Pais, M Galocha, IM Miranda, AG Rodrigues, MC Teixeira Microbiology Resource Announcements 8 (35), 10.1128/mra. 00278-19, 2019 | 5 | 2019 |
| Genomic evolution towards azole resistance in Candida glabrata clinical isolates unveils the importance of CgHxt4/6/7 in azole accumulation M Galocha, R Viana, P Pais, A Silva-Dias, M Cavalheiro, IM Miranda, ... Communications Biology 5 (1), 1118, 2022 | 4 | 2022 |
| Host-induced stress response in human pathogenic fungi R Viana, P Pais, M Cavalheiro, M Galocha, MC Teixeira Elsevier, 2021 | 2 | 2021 |
| Characterization of the Candida glabrata Transcription Factor CgMar1: Role in Azole Susceptibility P Pais, M Galocha, R Califórnia, R Viana, M Ola, M Okamoto, H Chibana, ... Journal of Fungi 8 (1), 61, 2022 | 1 | 2022 |
| Candida glabrata evolution towards posaconazole resistance: novel molecular insights MÃ Galocha Candida and Candidiasis 2021, Date: 2021/03/21-2021/03/27, Location: Online, 2021 | | 2021 |
| Genome-scale metabolic model of the human pathogen C. albicans: aiming the identification of promising new drug targets R Viana, O Dias, J Bastos, DRS Lagoa, M Galocha, I Rocha, MC Teixeira Universidade de Coimbra, 2019 | | 2019 |
| II11. Bioinformatics, Omics and Bionanotechnologies P433. Genome-scale metabolic model of the human pathogen C. albicans: aiming the identification of promising new drug targets R Viana, O Dias, J Bastos, D Lagoa, M Galocha, I Rocha, M Cacho | | |
